Liquid Biopsy MarketThe global liquid biopsy market is poised for substantial expansion, with an estimated revenue of USD 1,538.3 million in 2023. The market is projected to grow at an impressive ...
NEW YORK – UK-based startup Oxford Cancer Analytics is using the $11 million it has raised in a Series A financing to further develop and commercialize its protein-based lung cancer screening assay.
Pan-cancer microsatellite instability testing using a multiplex assay including long mononucleotide repeats. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium.